Szombathelyi Zsolt
research leaderMale0.0Global Dominance: 0.00%
A former research leader at Richter Gedeon Nyrt., Szombathelyi Zsolt played a pivotal role in the development of cariprazine, an antipsychotic medication that has significantly impacted the lives of nearly two million patients worldwide.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Szombathelyi Zsolt, the company's former research leader, spoke about the beginnings of the research that led to cariprazine.
Index - Tudomány - Közel kétmillió ember életét változtatta meg egy magyar gyógyszer, és még csak tízévesIndex.hu·
Hungary· 2025-09-18
Hungary· 2025-09-18
